Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists

Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonists

US Patent 12319682 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Compounds for treating disorders sensitive to serotoninergic regulation controll2020
Arylosulfonamides for the treatment of CNS diseases2015
Arylosulfonamides for the treatment of CNS diseases2015